Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/15/2021 27 3
Mefloquine hydrochloride Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 8 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/14/2021 37 37
Ruxolitinib Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/06/2021 8 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/05/2021 72 13
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Dec/22/2020 24 5
Chlorpromazine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 3 0
Mitoxantrone Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/04/2020 2 0
Imatinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/21/2020 4 0
Noscapine Potential treatment - pre-clinical evidence Experimental Antiviral Aug/20/2020 2 0